Literature DB >> 32484459

Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence.

Alexandre Alanio1,2,3.   

Abstract

Cryptococcus neoformans is an opportunistic yeast that is present worldwide and interacts with various organisms. In humans, it is responsible for cryptococcosis, a deadly invasive fungal infection that represents around 220,000 cases per year worldwide. Starting from the natural history of the disease in humans, there is accumulating evidence on the capacity of this organism to enter dormancy. In response to the harsh host environment, the yeast is able to adapt dramatically and escape the vigilance of the host's immune cells to survive. Indeed, the yeast exposed to the host takes on pleiotropic phenotypes, enabling the generation of populations in heterogeneous states, including dormancy, to eventually survive at low metabolic cost and revive in favorable conditions. The concept of dormancy has been validated in C. neoformans from both epidemiological and genotyping data, and more recently from the biological point of view with the characterization of dormancy through the description of viable but nonculturable cells.

Entities:  

Mesh:

Year:  2020        PMID: 32484459      PMCID: PMC7324190          DOI: 10.1172/JCI136223

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  118 in total

1.  Nosocomial transmission of cryptococcosis.

Authors:  Cheng-Yi Wang; Huey-Dong Wu; Po-Ren Hsueh
Journal:  N Engl J Med       Date:  2005-03-24       Impact factor: 91.245

2.  The viability and virulence of old cultures of tubercle bacilli; studies on 30-year-old broth cultures maintained at 37 degrees C.

Authors:  H J CORPER; M L COHN
Journal:  Tubercle       Date:  1951-11

3.  Survival and viability of nonculturableEscherichia coli andVibrio cholerae in the estuarine and marine environment.

Authors:  H S Xu; N Roberts; F L Singleton; R W Attwell; D J Grimes; R R Colwell
Journal:  Microb Ecol       Date:  1982-12       Impact factor: 4.552

4.  Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis.

Authors:  Feng Ye; Jia-xing Xie; Qing-si Zeng; Guo-qin Chen; Shu-qing Zhong; Nan-shan Zhong
Journal:  Lung       Date:  2012-01-14       Impact factor: 2.584

5.  Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components.

Authors:  Karen L Wozniak; Stuart M Levitz
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

6.  Mixed infections and In Vivo evolution in the human fungal pathogen Cryptococcus neoformans.

Authors:  Marie Desnos-Ollivier; Sweta Patel; Adam R Spaulding; Caroline Charlier; Dea Garcia-Hermoso; Kirsten Nielsen; Françoise Dromer
Journal:  MBio       Date:  2010-05-18       Impact factor: 7.867

Review 7.  Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts.

Authors:  John C Christianson; William Engber; David Andes
Journal:  Med Mycol       Date:  2003-06       Impact factor: 4.076

8.  Patients with long-term oral carriage harbor high-persister mutants of Candida albicans.

Authors:  Michael D Lafleur; Qingguo Qi; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

Review 9.  Cryptococcal lymphadenitis as a manifestation of immune reconstitution inflammatory syndrome in an HIV-positive patient: a case report and review of the literature.

Authors:  L Putignani; G Antonucci; M G Paglia; L Vincenzi; A Festa; P De Mori; L Loiacono; P Visca
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Jul-Sep       Impact factor: 3.219

Review 10.  Current Perspectives on Viable but Non-culturable State in Foodborne Pathogens.

Authors:  Xihong Zhao; Junliang Zhong; Caijiao Wei; Chii-Wann Lin; Tian Ding
Journal:  Front Microbiol       Date:  2017-04-04       Impact factor: 5.640

View more
  9 in total

1.  Increased risk of cancer in dogs and humans: a consequence of recent extension of lifespan beyond evolutionarily-determined limitations?

Authors:  Aaron L Sarver; Kelly M Makielski; Taylor A DePauw; Ashley J Schulte; Jaime F Modiano
Journal:  Aging Cancer       Date:  2022-02-23

2.  An Immunogenic and Slow-Growing Cryptococcal Strain Induces a Chronic Granulomatous Infection in Murine Lungs.

Authors:  Calla L Telzrow; Shannon Esher Righi; Natalia Castro-Lopez; Althea Campuzano; Jacob T Brooks; John M Carney; Floyd L Wormley; J Andrew Alspaugh
Journal:  Infect Immun       Date:  2022-05-19       Impact factor: 3.609

Review 3.  Microbe Profile: Cryptococcus neoformans species complex.

Authors:  Yong-Sun Bahn; Sheng Sun; Joseph Heitman; Xiaorong Lin
Journal:  Microbiology (Reading)       Date:  2020-09       Impact factor: 2.777

Review 4.  The state of latency in microbial pathogenesis.

Authors:  Liise-Anne Pirofski; Arturo Casadevall
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

5.  Genomic epidemiology of a Cryptococcus neoformans case cluster in Glasgow, Scotland, 2018.

Authors:  Rhys A Farrer; Andrew M Borman; Teresa Inkster; Matthew C Fisher; Elizabeth M Johnson; Christina A Cuomo
Journal:  Microb Genom       Date:  2021-02-23

6.  Clinical and Computed Tomography (CT) Characteristics of Pulmonary Nodules Caused by Cryptococcal Infection.

Authors:  Fang Chen; Yuan-Bing Liu; Bin-Jie Fu; Fa-Jin Lv; Zhi-Gang Chu
Journal:  Infect Drug Resist       Date:  2021-10-14       Impact factor: 4.003

7.  Use of Clinical Isolates to Establish Criteria for a Mouse Model of Latent Cryptococcus neoformans Infection.

Authors:  Minna Ding; Kyle D Smith; Darin L Wiesner; Judith N Nielsen; Katrina M Jackson; Kirsten Nielsen
Journal:  Front Cell Infect Microbiol       Date:  2022-02-02       Impact factor: 6.073

Review 8.  Elevated Intracranial Pressure in Cryptococcal Meningoencephalitis: Examining Old, New, and Promising Drug Therapies.

Authors:  Abdulaziz H Alanazi; Mir S Adil; Xiaorong Lin; Daniel B Chastain; Andrés F Henao-Martínez; Carlos Franco-Paredes; Payaningal R Somanath
Journal:  Pathogens       Date:  2022-07-10

9.  Epidemiological Characteristics and Drug Resistance Analysis of Cerebrospinal Fluid Microbial Infections in Wenzhou Area.

Authors:  Teng Zhou; Mengjiao Kuang; Shirui Huang; Jizhen Li; Qipeng Xie
Journal:  Infect Drug Resist       Date:  2021-06-03       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.